| LFT | latex fixation test; latex flocculation test; left fronto-transverse [fetal position]; liver functio... |
|---|---|
| LPBP | low-profile bioprosthesis |
| ULP | ultra low profile |
| ELF | elective low forceps; extremely low frequency |
| LBI | low back injury; low serum-bound iron |
| urethral pressure profile | The continual recording of pressure through a hole in the side of a small catheter as it is pulled (at a constant rate while either water or a gas is infused through the hole) from a point within the bladder, through the vesical neck, and down the entire urethra; a form of resistance measurement which gives a tracing indicative of the functional length of the urethra and the points of maximal urethral resistance. (05 Mar 2000) |
|---|---|
| lipid profile | Pattern of lipids in the blood. (A lipid profile usually includes the total cholesterol, high density lipoprotein (hdl) cholesterol, triglycerides, and the calculated low density lipoprotein (ldl) cholesterol. (12 Dec 1998) |
| liver profile | <investigation> A test that measures the blood serum level of several enzymes produced by the liver. An elevated liver function test is a sign of possible liver damage. Examples include: prothrombin time, PTT, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, gamma glutamyl transpeptidase, alkaline phosphatase and serum albumin. (14 Oct 1997) |
| Lovibond's profile sign | The angle made at the meeting of the proximal nail fold and the nail plate when viewed from the radial aspect; normally, less than 180 |
| back pain, low | Symptoms in the low back can relate to the bony lumbar spine, discs between the vertebrae, ligaments around the spine and discs, spinal cord and nerves, muscles of the low back, internal organs of the pelvis and abdomen, and the skin covering the lumbar area. The low back, or lumbar area, functions in structural support, movement, and protection of certain body tissue. (12 Dec 1998) |
| blood sugar, low | The sugar here is glucose. Low blood glucose constitutes hypoglycaemia. Hypoglycaemia is only significant when it is associated with symptoms. It has many causes including drugs, liver disease, surgical absence of the stomach, pre-diabetes, and rare tumours that release excess insulin. (12 Dec 1998) |
| cardiac output, low | A state of subnormal or depressed cardiac output, usually seen in patients with heart failure secondary to coronary artery, hypertensive, primary myocardial, valvular, or pericardial disease. (12 Dec 1998) |
| very low density lipoprotein | <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats (particularly triglycerides) in the bloodstream. Elevations in very low density lipoprotein in the bloodstream are associated with an increased risk of atherosclerosis and coronary artery disease. Acronym: VLDL (18 Nov 1997) |
| Castellani-Low sign | <clinical sign> A fine tremor of the tongue observed in sleeping sickness. (05 Mar 2000) |
| mean lower low water | <marine biology> The average height of the lower low waters over a 19-year period. For shorter periods of observations, corrections are applied to eliminate known variations and reduce the result to the equivalent of a mean 19-year value. (09 Oct 1997) |
| mean low water | <marine biology> The average height of the low waters over a 19-year period. For shorter periods of observations, corrections are applied to eliminate known variations and reduce the result to the equivalent of a mean 19-year value. All low-water heights are included in the average where the type of tide is either semidiurnal or mixed. Only the lower low-water heights are included in the average where the type of tide is diurnal. So determined, mean low water in the latter case is the same as mean lower low water. (09 Oct 1997) |
| placenta, low | Location of the placenta in the lower part of the uterus (womb) so that the placenta partially or completely covers the cervix. Also known as a placenta previa. (12 Dec 1998) |
| heparin, low-molecular-weight | <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. Pharmacological action: anticoagulant, fibrinolytic agent. (12 Dec 1998) |
| infant, low birth weight | An infant having a birth weight of 2500 gm. (5.5 lb.) or less but infant, very low birth weight is available for infants having a birth weight of 1500 grams (3.3 lb.) or less. (12 Dec 1998) |
| infant, very low birth weight | An infant having a birth weight of 1500 grams (3.3 lb.) or less. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|